Over the last few years, biotechnology in Italy has become an established industrial reality in all fields of application, including human health, agro-food, and industry. The path has been difficult, but even so the biotech sector has progressed enormously, resulting in well-earned respect on an international level - an unimaginable achievement just a few years ago.
The 2011 edition of the "Italian Biotechnology Report" by Assobiotec and Ernst & Young, in cooperation with Farmindustria and the Italian Trade Commission, shows that the Italian biotech industry has responded positively to the difficult international economic situation by confirming the growth and consolidation trend which has characterized this field over the last decade. This is of major importance for Assobiotec, the national association for the development of biotechnology - which in 2011, celebrated its 25th anniversary. Assobiotec represents companies and technological and scientific parks operating in Italy in the various sectors of Life Sciences.
Italian biotech companies continually show that they are remarkably capable of maximizing investments in terms of value creation, that they can count on absolutely competitive scientific excellence and on the presence of an important link with academic research and, most of all, that they are still driven by the spirit of initiative that characterizes so many successful stories of Italian entrepreneurs. These are the reasons that explain the significant growth rate of biotech within the country.
For more information on this dynamic sector go to Assobiotec's website at http://assobiotec.federchimica.it/ and for a current directory of Italian companies involved in the sector go to http://assobiotec.federchimica.it/default/italian-biotech-database.aspx